Semaphorin 3F Inhibits Breast Cancer Metastasis by Regulating the Akt-mTOR and TGFβ Signaling Pathways Via Neuropilin-2

Investigators found that exogenous SEMA3F inhibited phosphorylation of Akt and mTOR downstream kinase S6K in MDA-MB-231 and MCF7 cells via neuropilin-2 receptor.